GE Healthcare, IntrinsiQ to develop oncology EMR

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

GE Healthcare announced a collaboration with cancer care software provider IntrinsiQ LLC, to develop an EMR (electronic medical record) that is integrated with a cancer patient’s oncology information.

IntrinsiQ’s IntelliDose software is able to automate much of the chemotherapy order entry process and thereby reduce the potential for error by producing legible, complete and electronically checked orders. The effort will interface these capabilities with GE’s Centricity Electronic Medical Record so that clinicians will have access to information about patients undergoing chemotherapy, including drug administration records and nurse notes.
“IntelliDose is designed to help automate the administration of chemotherapy using practice-specific standards including automated error checking features that meet the recommendations of the Institute of Medicine report for safe medical practice,” Bill Wisotzkey, general manager for IntrinsiQ’s IntelliDose Solutions.

One facility that has put the integrated system to use is Westchester Medical Group, a 67-physician, multi-specialty group located in White Plains, N.Y.

“Previously chemotherapy treatment was calculated and documented using pen and paper,” said Simeon Schwartz, MD, chief executive officer of Westchester Medical Group. “Not only was this extremely inefficient but more importantly it could lead to potential human error. By interfacing our Centricity EMR system with the Intellidose software, our practice has virtually gone from the Flintstones to the Jetsons in a matter of weeks.”